Headline
The latest stories from AHA Today.
UnitedHealthcare has delayed from April 1, 2021, until Jan. 1, 2022, its requirement that certain in-network laboratories report their unique laboratory-specific codes along with other information for the overwhelming majority of freestanding and outpatient laboratory testing services.
The Food and Drug Administration authorized administering the monoclonal antibodies casirivimab and imdevimab together to certain COVID-19 outpatients at risk for severe disease.
Drug maker AstraZeneca said it will seek an emergency use authorization for its AZD1222 vaccine candidate for SARS-CoV-2 following positive high-level results from an interim analysis of ongoing clinical trials.
Learn how Rogers Behavioral Health, based in Oconomowoc, Wisc., is using the LEAN process improvement methodology to optimize value for patients during the pandemic.
Hospital outpatient departments, critical access hospitals, rural health clinics and other eligible providers may apply through Jan. 3 to participate in the Value in Opioid Use Disorder Treatment demonstration.
The Centers for Medicare & Medicaid Services has selected 916 primary care practices and 37 regional health plan partners to participate in the Primary Care First model beginning Jan. 1.
The Centers for Medicare & Medicaid Services will host a Dec. 8 webinar on its final rule requiring hospitals to disclose payer-specific negotiated rates effective Jan. 1.
The Trump administration announced two actions that it claims will lower prescription drug prices.
The Department of Health and Human Services released its final rules with changes to the Stark Law and Anti-kickback statute. AHA members will receive a Special Bulletin highlighting key changes.
Sarah Krevans, president and CEO of Sutter Health, joined AHA Board Chair Melinda Estes, M.D., yesterday to discuss how hospitals can move from relief, recovery, and rebuilding to reimagining and innovation.